HighVista Strategies’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
EHC
HighVista Strategies's NVO Position: Q2 2021 in Review
HighVista Strategies sold out of Novo Nordisk (NVO) in Q2 2021, closing a stake of 10,226 shares — an estimated $345K sold.
HighVista Strategies first reported a position in NVO in Q1 2015 and held it in 17 quarters. The position peaked at $4.2M in Q1 2015. 735 funds tracked by Wall St. Rank hold NVO as of Q2 2021.
- HighVista Strategies reported no remaining Novo Nordisk position as of Q2 2021 after selling out during the quarter.
- HighVista Strategies sold 10,226 Novo Nordisk shares in Q2 2021, an estimated $345K.
- HighVista Strategies first reported a position in Novo Nordisk in Q1 2015 and held it in 17 quarters.
- HighVista Strategies's Novo Nordisk position peaked at $4.2M in Q1 2015.
- 735 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2021.
Based on HighVista Strategies's 13F filing for Q2 2021, filed 16 Aug 2021.